Xiaodong Wang - 09 Sep 2025 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Role
Director, Chair, Scientific Advisory Brd
Signature
/s/ Qing Nian, as Attorney-in-Fact
Issuer symbol
ONC
Transactions as of
09 Sep 2025
Net transactions value
$0
Form type
4
Filing time
11 Sep 2025, 17:12:14 UTC
Previous filing
25 Jun 2025
Next filing
12 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wang Xiaodong Director, Chair, Scientific Advisory Brd C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND /s/ Qing Nian, as Attorney-in-Fact 11 Sep 2025 0001662982

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONC Ordinary Shares Gift $0 -148,096 -2.9% $0.000000 5,006,674 09 Sep 2025 Direct F1
holding ONC Ordinary Shares 1,025,063 09 Sep 2025 See Footnote F2
holding ONC Ordinary Shares 3,953,100 09 Sep 2025 See Footnote F3
holding ONC Ordinary Shares 50 09 Sep 2025 See Footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Bona fide gift(s) of shares which are exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5.
F2 These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
F3 These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
F4 These securities are held by the spouse of the Reporting Person.